Browse by Poster Presenter

Skip to main content

ACoP 2024 Main banner

Conference Program

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

A
Abdelmageed, Mai

Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida & Clinical Pharmacology and Pharmacometrics Department, Biogen MA Inc., USA
(T-001) A Model-based Pharmacokinetic Simulation Tool to Aid Dose Selection of Antisense Oligonucleotides Administered Intrathecally in Pediatrics
Mai Abdelmageed
Favorite
Abrams, Ruth

Daiichi Sankyo
(T-002) Representation of antibodies is key to generate a predictive vaccine quantitative systems pharmacology (QSP) model
Ruth Abrams
Favorite
Adam, Brian

Certara, Inc.
(M-001) Direct and Indirect Exposure-Response Modeling for Transthyretin Amyloid Cardiomyopathy Treated with Acoramidis
Brian Adam
Favorite
Adams, Dana

Genentech, Inc.
(W-035) Systems model to predict fractional exhaled nitric oxide response to inhaled JAK inhibitors in patients with mild to moderate asthma
Dana Adams
Favorite
Afzal, Nasrin

Genmab
(W-001) Leveraging quantitative systems pharmacology (QSP) modeling to understand effects of corticosteroids on immune cells and cytokine release following administration of SC Epcoritamab
Nasrin Afzal
Favorite
Ahadieh, Sima

Pfizer
(M-002) A Longitudinal Model-based Meta-Analysis (MBMA) of Body Weight in Obesity Trials
Sima Ahadieh
Favorite
Ahmed, Sameed

Takeda Pharmaceuticals
(T-005) A novel PBPK/PD model of preclinical data projects the human pharmacologically active dose of a Biologic that modulates immunosuppressive immune cells in the tumor microenvironment
Sameed Ahmed
Favorite
Al Hroot, Jomana

University of Iowa
(M-003) Determining an Appropriate Fosfomycin Dosing Regimen in Pneumonia Patients by Utilizing minimal PBPK Modeling and Target Attainment Analysis
Jomana Al Hroot
Favorite
Al Sahlawi, Sulafa

University of Florida
(T-006) Inhibitory Potential of Cannabidiol on Major CYP450s Enzymes: Insights from Physiological-based Pharmacokinetic Modeling
Sulafa Al Sahlawi
Favorite
Alexander, Gregory

Janssen Research & Development, La Jolla, California, USA.
(M-004) MBMA Bridging Models as A Tool for Exploration of Clinical Endpoints in Unstudied Indications.
Gregory Alexander
Favorite
Anderson, Wes

Critical Path Institute
(W-003) Leveraging Machine Learning and Real-World Data: Time-to-Event Analysis of COVID-19 Patients Using Electronic Health Records
Wes Anderson
Favorite
An, Yegwon

The State University of New York at Buffalo, School of Pharmacy & Pharmaceutical Sciences
(W-002) Dual Physiologically-based Pharmacokinetics Models of Nano-Liposomal (Nal-IRI) and Non-Liposomal Irinotecan in Ewing’s Family Tumor Xenograft
Yegwon An
Favorite
Arsène, Simon

Novadiscovery
(M-005) Coupling A Quantitative Systems Pharmacology Model With A Simple Statistical Layer To Predict Asthma Exacerbation Rate Reduction From Allergen Challenge Results
Simon Arsène
Favorite
(M-006) An innovative paradigm for non-small cell lung cancer clinical trial simulations through the Integration of a quantitative systemic pharmacology model and pharmacodynamic model of gemcitabine
Simon Arsène
Favorite
(M-007) Leveraging AI for improved reproducibility of mathematical disease models: insights from a retinitis pigmentosa case study
Simon Arsène
Favorite
(M-008) A within-host dynamic model of Bordetella pertussis to support vaccine development
Simon Arsène
Favorite
Arul Dhas, Blessed Winston

Christian Medical College, Vellore
(T-142) PK-PD modeling of doxycycline, azithromycin, and their combination in treating severe scrub typhus using a general pharmacodynamic interaction (GPDI) model.
Blessed Winston Arul Dhas
Favorite
Attah, Michael

Purdue/IUPUI
(T-007) Population Pharmacokinetics of Enoxaparin in Neonates and Infants
Michael Attah
Favorite
Avila Ponce De Leon, Marco
(T-017) Application of an advanced gut PBPK model to characterize intestinal transport and P-glycoprotein-mediated drug-drug interaction: a case study with Digoxin and Clarithromycin
Marco Avila Ponce De Leon
Favorite
Ayyar, Vivaswath

J&J Innovative Medicine
(T-008) Quantitative Systems Pharmacology (QSP) model for combined targeting of BAFF and CD40 pathways in systemic lupus erythematosus
Vivaswath Ayyar
Favorite